Top Tech Companies (124)
EncrypGen makes next-generation software to aide in safely storing and sharing genomic data for research and science, and to allow users to manage their own data and sell it to researchers.
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be...
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt...
Synchron is a leading implantable brain computer interface company. The stentrode is the first commercial implantable brain computer interface to receive an FDA IDE for in human clinical trials.
Meet IFF: We boldly bring together science and creativity to create what the world needs. An industry leader in food, beverage, health and biosciences, we create essential solutions – from global icons to unexpected innovations and experiences. Equal parts outspoken and analytical, our international collective of thinkers working with customers to bring scents, tastes, experiences, ingredients and solutions for products people crave. With...
Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 90 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process...
The mission of The New York Stem Cell Foundation is to cure the major diseases of our time through stem cell research. In addition to conducting innovative stem cell research in our own safe haven laboratories, NYSCF also supports and convenes global stem cell thought leaders and the broader stem cell community – all with the focus on getting to patients....
Code Ocean is where great computational research is created, organized, and shared in one place. It is the best way for research teams to standardize research workflow, plus track and reproduce all computations and discoveries. Research and development organizations benefit from lower IT costs, automation to operationalize reproducibility, and saving wasted researcher and collaboration time. Our mission is to make computational...
The leading AI platform for transforming medical data into actionable insights
AlgiKnit is creating eco-conscious, renewable yarns for the circular economy. We’re developing durable yet rapidly degradable yarns from kelp, one of the most regenerative organisms on the planet. Our material is built for everyone: a functional and accessible resource without environmental harm. We’re envisioning a future where the textile industry operates in a closed-loop product lifecycle, utilizing materials with a...
We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with...
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options...
Melonfrost has created a novel way to modify living things. By combining machine learning and evolutionary biology, our Maia™ software can steer the evolution of organisms in real-time. Our platform, which includes our proprietary Evolution Reactor™, is the dawn of the next generation of biotechnology tools - allowing us to more efficiently solve problems in therapeutics, biomaterials, food, and energy.
Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve....
Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures. At Ovid, we are pursuing small molecule compounds with untapped...
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO’s foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medical College and the University of California, San Diego, two...
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose...
